IN150 > (Ibandronate Sodium 150 mg (base))
Pill with imprint IN150 > is White, Capsule-shape and has been identified as Ibandronate Sodium 150 mg (base). It is supplied by Watson Laboratories, Inc..
Ibandronate is used in the treatment of prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for IN150 >
Ibandronate Sodium
- Imprint:
- IN150 >
- Strength:
- 150 mg (base)
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Bisphosphonates
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- 00591-3770
More about ibandronate
- Ibandronate Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 48 Reviews
- Drug class: bisphosphonates
- FDA Alerts (3)
Consumer resources
- Ibandronate oral/injection
- Ibandronate Injection
- Ibandronate Tablets
- Ibandronate Intravenous (Advanced Reading)
- Ibandronate Oral, Injection (Advanced Reading)
Other brands: Boniva
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
